OTREXUP
Antares Pharma Inc.
Trademark Registered: 2016-06-28
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85802703 |
| Registration Number | 4988928 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Allan Fanucci |
| Attorney Docket Number | 088066-01001 |
| Law Office Assigned | M20 |
| Employee Name | HUGHITT, ELIZABETH A |
Timeline
| 2012-12-14 | Application Filed |
| 2014-01-00 | Date of First Use |
| 2015-09-01 | Published for Opposition |
| 2016-05-24 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-06-28 | Status: Live/Registered |
| 2016-06-28 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Antares Pharma Inc. |
| Address | 100 Princeton South Corp. Ctr. #300 Ewing DE 08628 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-arthritic compositions and preparations; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the treatment and prevention of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, namely, rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseases, namely, arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2012-12-18 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2013-01-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2013-03-18 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2013-03-20 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2013-03-20 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2013-03-20 | 6 GNS3 O:Outgoing Correspondence |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2013-09-23 | 7 RCSC S: |
| NON-FINAL ACTION WRITTEN | 2014-03-24 | 8 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2014-03-24 | 9 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2014-03-24 | 10 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-09-24 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-09-24 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-09-25 | 13 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2014-10-07 | 14 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2014-10-07 | 15 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2014-10-07 | 16 GNFN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2015-01-22 | 17 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2015-01-22 | 18 ARAA I:Incoming Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2015-04-07 | 19 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2015-04-08 | 20 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2015-04-08 | 21 EXPI T:TTAB Proceeding |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2015-04-07 | 22 ERFR I:Incoming Correspondence |
| ASSIGNED TO LIE | 2015-04-10 | 23 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-04-16 | 24 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-04-16 | 25 TEME I:Incoming Correspondence |
| ACTION CONTINUING FINAL - COMPLETED | 2015-04-23 | 26 CNCF S: |
| ACTION DENYING REQ FOR RECON E-MAILED | 2015-04-23 | 27 GECD O:Outgoing Correspondence |
| NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | 2015-04-23 | 28 GEA1 O:Outgoing Correspondence |
| EXPARTE APPEAL DISMISSED AS MOOT | 2015-07-17 | 29 EXDM T:TTAB Proceeding |
| EXPARTE APPEAL TERMINATED | 2015-07-17 | 30 EXPT T:TTAB Proceeding |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-07-20 | 31 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-07-30 | 32 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-08-12 | 33 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2015-09-01 | 34 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-09-01 | 35 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2015-10-27 | 36 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2016-04-27 | 37 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-05-22 | 38 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2016-04-27 | 39 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2016-05-23 | 40 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2016-05-24 | 41 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2016-05-25 | 42 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-06-28 | 43 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-06-28 | 44 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2022-06-27 | 45 E815 I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2022-08-24 | 46 ASGN I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-01-11 | 47 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-01-11 | 48 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-01-11 | 49 NA85 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OTREXUP 85802703 4988928 Live/Registered |
Antares Pharma Inc. 2012-12-14 |
 OTREXUP 85788191 5161291 Live/Registered |
Antares Pharma Inc. 2012-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 